Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Japanese (NIKKEI) Healthcare Sector Analysis

UpdatedMar 02, 2026
DataAggregated Company Financials
Companies204
  • 7D3.7%
  • 3M14.3%
  • 1Y27.8%
  • YTD11.5%

The Healthcare industry is up 3.7% in the last week, with M3 up 9.6%. This means that the industry has gained 28% over the past year. As for the next few years, earnings are expected to grow by 9.5% per annum.

Sector Valuation and Performance

Has the Japanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 04 Mar 2026JP¥79.7tJP¥38.9tJP¥3.1t16.6x26x2x
Fri, 30 Jan 2026JP¥70.4tJP¥38.4tJP¥2.8t16x25.6x1.8x
Sun, 28 Dec 2025JP¥71.1tJP¥38.4tJP¥2.7t16.5x25.9x1.9x
Tue, 25 Nov 2025JP¥70.3tJP¥38.5tJP¥2.8t16.5x25.5x1.8x
Thu, 23 Oct 2025JP¥67.2tJP¥38.1tJP¥2.7t15.5x25.1x1.8x
Sat, 20 Sep 2025JP¥65.3tJP¥38.2tJP¥2.7t15.8x24.4x1.7x
Mon, 18 Aug 2025JP¥64.2tJP¥38.2tJP¥2.7t15.4x23.9x1.7x
Wed, 16 Jul 2025JP¥61.6tJP¥38.1tJP¥2.6t14.7x23.4x1.6x
Fri, 13 Jun 2025JP¥63.8tJP¥38.1tJP¥2.6t14.7x24.2x1.7x
Sun, 11 May 2025JP¥64.5tJP¥37.9tJP¥2.5t14.8x26.3x1.7x
Tue, 08 Apr 2025JP¥57.4tJP¥37.5tJP¥2.4t12.8x24x1.5x
Thu, 06 Mar 2025JP¥64.2tJP¥37.5tJP¥2.4t15.2x26.8x1.7x
Sat, 01 Feb 2025JP¥66.5tJP¥36.8tJP¥2.2t16.6x30.8x1.8x
Mon, 30 Dec 2024JP¥67.8tJP¥36.7tJP¥2.2t16.5x30.3x1.8x
Wed, 27 Nov 2024JP¥67.1tJP¥36.7tJP¥2.2t16.2x29.9x1.8x
Fri, 25 Oct 2024JP¥70.0tJP¥36.0tJP¥2.0t17.2x35.3x1.9x
Sun, 22 Sep 2024JP¥69.4tJP¥36.0tJP¥2.0t17.6x35x1.9x
Tue, 20 Aug 2024JP¥70.3tJP¥36.0tJP¥2.0t16.7x35.4x2x
Thu, 18 Jul 2024JP¥71.3tJP¥35.1tJP¥1.8t18.6x38.6x2x
Sat, 15 Jun 2024JP¥64.7tJP¥35.3tJP¥1.9t17.7x34.7x1.8x
Mon, 13 May 2024JP¥65.0tJP¥35.2tJP¥2.0t17.6x33.2x1.8x
Wed, 10 Apr 2024JP¥64.7tJP¥35.1tJP¥2.0t17.8x33x1.8x
Fri, 08 Mar 2024JP¥68.9tJP¥35.1tJP¥2.0t18.7x35.1x2x
Sun, 04 Feb 2024JP¥64.8tJP¥34.9tJP¥2.1t19.1x31.3x1.9x
Tue, 02 Jan 2024JP¥62.9tJP¥35.0tJP¥2.2t18.3x29.2x1.8x
Thu, 30 Nov 2023JP¥63.3tJP¥35.0tJP¥2.2t17.5x29.4x1.8x
Sat, 28 Oct 2023JP¥59.9tJP¥34.6tJP¥2.2t17.2x27.5x1.7x
Mon, 25 Sep 2023JP¥62.7tJP¥34.5tJP¥2.3t17.8x27.6x1.8x
Wed, 23 Aug 2023JP¥62.7tJP¥34.5tJP¥2.3t17.8x27.7x1.8x
Fri, 21 Jul 2023JP¥62.1tJP¥34.0tJP¥2.3t18.3x26.8x1.8x
Sun, 18 Jun 2023JP¥67.5tJP¥33.9tJP¥2.3t18.7x29.1x2x
Tue, 16 May 2023JP¥63.1tJP¥33.8tJP¥2.3t18.2x27.2x1.9x
Thu, 13 Apr 2023JP¥60.6tJP¥33.5tJP¥2.3t17x26.3x1.8x
Sat, 11 Mar 2023JP¥59.8tJP¥33.5tJP¥2.3t17x26x1.8x
Price to Earnings Ratio

26x


Total Market Cap: JP¥59.8tTotal Earnings: JP¥2.3tTotal Revenue: JP¥33.5tTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Healthcare Sector Price to Earnings3Y Average 28.8x202420252026
Current Industry PE
  • Investors are relatively neutral on the Japanese Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 28.8x.
  • The 3-year average PS ratio of 1.8x is lower than the industry's current PS ratio of 2.0x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 10% per year over the last three years.
  • Revenues for these companies have grown 5.1% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare sector?

JP Market3.27%
Healthcare3.67%
Biotech7.10%
Healthtech5.84%
Medical Equipment4.48%
Healthcare Services4.22%
Pharma3.22%
Life Sciences0.67%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry, which is trading close to its 3-year average PE ratio of 31.0x.
    • Analysts are expecting annual earnings growth of 10.9%, which is higher than its past year's earnings decline of 3.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 43% over the next 5 years.
  • This is better than its past earnings decline of 20% per year.
  • In contrast, the Healthcare Services industry is expected to see its earnings grow by 4.9% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
2413 M3JP¥1.64k9.6%
+JP¥88.0b		-8.5%PE22.2x
4543 TerumoJP¥2.01k2.2%
+JP¥64.9b		-25.5%PE23.2x
6869 SysmexJP¥1.47k7.6%
+JP¥64.2b		-45.5%PE20.4x
7747 Asahi InteccJP¥3.30k5.0%
+JP¥41.7b		38.5%PE49.5x
2160 GNI GroupJP¥3.19k10.7%
+JP¥17.2b		0.3%PS6.6x

Latest News

4506
JP¥1,959.00
Sumitomo Pharma
7D
-12.6%
1Y
184.3%
4502
JP¥5,727.00
Takeda Pharmaceutical
7D
-1.6%
1Y
28.7%
4503
JP¥2,399.50
Astellas Pharma
7D
-4.3%
1Y
64.6%
4568
JP¥2,839.00
Daiichi Sankyo Company
7D
-4.7%
1Y
-22.7%
2413
JP¥1,639.00
M3
7D
9.6%
1Y
-8.5%
4519
JP¥9,872.00
Chugai Pharmaceutical
7D
-2.3%
1Y
32.9%
7747
JP¥3,299.00
Asahi Intecc
7D
5.0%
1Y
38.5%
6869
JP¥1,465.50
Sysmex
7D
7.6%
1Y
-45.5%
4543
JP¥2,013.50
Terumo
7D
2.2%
1Y
-25.5%

4543: Higher Profit Margins And Stable Discount Rate Will Support Long Term Upside

Analysts have kept their fair value estimate for Terumo steady at ¥3,700.00, citing slightly higher discount rate assumptions, a modest adjustment to revenue growth expectations, and a small uplift in projected profit margins and future P/E as the key drivers behind the unchanged price target. Valuation Changes Fair Value: Kept unchanged at ¥3,700.00, indicating no adjustment to the overall valuation anchor.
4578
JP¥10,135.00
Otsuka Holdings
7D
-2.8%
1Y
36.8%

4578: Margin Optimism Around Recent Upgrade Will Ultimately Prove Overpriced

Analysts have maintained their ¥8,000 price target on Otsuka Holdings, citing updated assumptions for slower revenue growth, slightly higher profit margins, a modestly higher P/E multiple, and a small adjustment to the discount rate following recent research updates. Analyst Commentary Recent research updates around the ¥8,000 price target reflect a mixed tone, with some optimism around profitability and valuation, but also a clear set of risks that bearish analysts continue to highlight for readers to monitor.
2160
JP¥3,185.00
GNI Group
7D
10.7%
1Y
0.3%
6960
JP¥9,940.00
Fukuda Denshi
7D
4.6%
1Y
50.8%

Return Trends At Fukuda Denshi (TSE:6960) Aren't Appealing

Feb 11
Return Trends At Fukuda Denshi (TSE:6960) Aren't Appealing
4588
JP¥2,814.00
Oncolys BioPharma
7D
21.9%
1Y
295.8%
7741
JP¥28,310.00
HOYA
7D
-2.7%
1Y
56.9%

HOYA Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 03
HOYA Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
4507
JP¥3,497.00
Shionogi
7D
-3.7%
1Y
51.9%
7777
JP¥671.00
3-D Matrix
7D
19.6%
1Y
330.1%

3-D Matrix, Ltd.'s (TSE:7777) Price Is Right But Growth Is Lacking After Shares Rocket 46%

Jan 16
3-D Matrix, Ltd.'s (TSE:7777) Price Is Right But Growth Is Lacking After Shares Rocket 46%